Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung CancerGrant A. Howe, Christina Addison, Mohamed S. Hasim et al.|PLoS ONE|2016Cited by 41
Eastern Canadian Colorectal Cancer Consensus Conference: Setting the Limits of Resectable DiseaseMichael M. Vickers, Timothy R. Asmis, Benoît Samson et al.|Current Oncology|2010Cited by 22